Challenges and solutions to embed cancer survivorship research and innovation within the EU Cancer Mission
- PMID: 34053182
- PMCID: PMC8253087
- DOI: 10.1002/1878-0261.13022
Challenges and solutions to embed cancer survivorship research and innovation within the EU Cancer Mission
Abstract
We have reached a watershed moment in Europe in our efforts to ensure increased survival and better outcomes for cancer patients. The EU Cancer Mission and the European Beating Cancer Plan together provide an unrivalled opportunity to make significant inroads into a disease that kills over 1.7 million European citizens annually. Harnessing these twin pillars of cancer research and cancer control can be transformative for the European cancer community and in particular for the European cancer patient. However, from a research perspective, in order to fully realise these benefits, we need to ensure that all aspects of the cancer continuum are addressed. Previous research efforts have focussed more on the diagnosis and treatment of cancer, whereas cancer survivorship, to date, has been overlooked. Here, we aim to redress this balance, by identifying the key challenges in cancer survivorship research that need to be addressed and proposing a series of recommended solutions, which, if acted upon, would deliver significant benefits for the nearly 20 million cancer survivors in Europe. To achieve this, we propose the development of a clearly articulated and sustainably funded European Cancer Survivorship Research and Innovation Plan. Embedding this plan within the framework of the EU Cancer Mission would be transformative for cancer survivors and society.
Keywords: EU Cancer Mission; Europe's Beating Cancer Plan; cancer survivorship; living with and beyond cancer; survivorship research.
© 2021 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Conflict of interest statement
ML has received honoraria from Pfizer, EMD Serono and Roche for presentations unrelated to this work. ML has received an unrestricted educational grant from Pfizer for research unrelated to this work. FDL, PL, FSM, SN, GS and FM declare no conflict of interest.
References
-
- Selby P, Liu L, Downing A, Is B, Wilson R, Stephens R, Meunier F, Rochon J, Morris E, Seymour M et␣al. (2019) How can clinical research improve European health outcomes in cancer? J Cancer Policy 20, 100182, 1–6.
-
- De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E et␣al. (2014) Cancer survival in Europe 1999‐2007 by country and age: results of EUROCARE‐5 – a population‐based study. Lancet Oncol 15, 23–34. - PubMed
-
- Lawler M, Naredi P, Cufer T, Banks I, Lievens Y, Vassal G, Aapro M, Sotlar MJ, Philip T, Jassem J et␣al. (2019) Moonshot or groundshot: addressing Europe's cancer challenge through a patient‐focused, data‐enabled lens. Lancet Oncol 20, 1482–1485. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
